Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
‘Regulatory Flexibility’ For Innovent/Lilly’s Sintilimab Not Warranted, US FDA Says
Feb 08 2022
•
By
Sue Sutter
FDA is not exactly bending over backwards to approve sintilimab. • Source: Alamy
More from US FDA Performance Tracker
More from Regulatory Trackers